Francesca Bobbio‐Pallavicini

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

Francesca Bobbio‐Pallavicini, Claudia Alpini, Roberto Caporali et al. · Arthritis Research & Therapy · 2004 · 163 citations · Full text

Life Sciences, Immunology, Pharmacology +17

TNF‐α Antagonist Survival Rate in a Cohort of Rheumatoid Arthritis Patients Observed under Conditions of Standard Clinical Practice

Antonio Marchesoni, Eleonora Zaccara, Roberto Gorla et al. · Annals of the New York Academy of Sciences · 2009 · 157 citations

Medicine, Pharmacology, Pharmacotherapy +12

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor α inhibitors in rheumatoid arthritis

Francesca Bobbio‐Pallavicini, Roberto Caporali, Claudia Alpini et al. · Annals of the Rheumatic Diseases · 2006 · 144 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.

Luana Mancarella, Francesca Bobbio‐Pallavicini, Fulvia Ceccarelli et al. · PubMed · 2007 · 142 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study

Elisa Gremese, Fausto Salaffi, Silvia Laura Bosello et al. · Annals of the Rheumatic Diseases · 2012 · 133 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15